DoW Peer Reviewed Cancer, Clinical Trial Award Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on…
Sign in to start building your grant-ready profile
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.